Tue, Jul 29, 2014, 8:29 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

Insmed Incorporated Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • sixftleprechaun sixftleprechaun Aug 11, 2007 11:25 AM Flag

    How much pain can you take?

    I thought about it and Insmed is very different for many different reasons from examples of 10+0 baggers.
    Insmed has 2 indications that they are shooting for at this time.That will make or break the company.Both are about 300M if both can survive,if both can get money to do a Phase3 trial.

    Insmed is not just getting started.They have flooded the street with shares just to stay alive NOW, because their first drug failed and then they lost the trial.They are not an example of a Biotech who has a molecule that 10 years later survives.They are a company that has stumbled badly in years past so your analogy is weak.Insmed has some good possibilities but my posts have been? Is this a "from the ashes" story" or is this a case of big money crushing a small company and taking the goods.There are far many more Biotech stories where shareholders got the short end of the stick.

 
INSM
17.50+0.40(+2.34%)Jul 29 3:59 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.